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Canine oral papillomavirus (COPV) infection is used in vaccine development against mucosal papillomaviruses. The
predictable, spontaneous regression of the papillomas makes this an attractive system for analysis of cellular immunity.
Immunohistochemical analysis of the timing and phenotype of immune cell infiltration revealed a marked influx of leukocytes
during wart regression, including abundant CD41 and CD81 cells, with CD41 cells being most numerous. Comparison of
these findings, and those of immunohistochemistry using TCRab-, TCRgd-, CD1a-, CD1c-, CD11a-, CD11b-, CD11c-, CD18-,
CD21-, and CD49d-specific monoclonal antibodies, with previously published work in the human, ox, and rabbit models
revealed important differences between these systems. Unlike bovine papillomavirus lesions, those of COPV do not have a
significant gamma/delta T-cell infiltrate. Furthermore, COPV lesions had numerous CD41 cells, unlike cottontail rabbit
papillomavirus lesions. The lymphocyte infiltrate in the dog resembled that in human papillomavirus lesions, indicating that
COPV is an appropriate model for human papillomavirus immunity. © 2001 Academic Press
Key Words: HPV; COPV; immunity; animal models; immunohistochemistry.INTRODUCTION
Papillomaviruses have been associated with numer-
ous benign lesions including warts of the skin, oral
cavity, larynx, and anogenital region (Shah and Howley,
1996). Some of the lesions regress spontaneously but
others prove refractory to treatment (Beutner and Fe-
renczy, 1997). The impact of benign papillomavirus infec-
tions is increased in people immunosuppressed thera-
peutically or from HIV infection (Palefsky et al., 1998). In
addition to the benign or low-risk human papillomavirus
(HPV) infections of the genital tract (e.g., HPV-6 and -11),
there are papillomavirus types associated with a high
risk of progression to malignancy (e.g., HPV-16, -18, -31).
The association between these high-risk papillomavi-
ruses and the development of cervical carcinoma is
strong enough for HPV-16 and HPV-18 to be defined as
carcinogens (Anonymous, 1996) and it now seems pos-
sible that all cases of cervical cancer may be associated
with HPV (Walboomers et al., 1999). The high frequency
of papillomavirus infections, the severity of the lesions,
and the inadequacy of current therapies have led to
intense efforts to understand the biology and immunity
1 To whom reprint requests should be addressed at Division of
eterinary and Biomedical Sciences, Murdoch University, Murdoch,
outh Street, Western Australia 6150. Fax: 61-(0)8-9310 4144. E-mail:
icholls@numbat.murdoch.edu.au.
31associated with these viruses. Because of the species
and tissue specificity of papillomaviruses, and their re-
quirement for differentiating epithelia to complete the life
cycle (Stanley, 1994a,b), only recently have methods
been developed for their propagation in vitro (Frattini et
al., 1996; Meyers et al., 1992; White et al., 1998). Despite
this, there remains a need for in vivo studies of papillo-
mavirus biology and host immunity, indeed animal mod-
els have been described recently as the “gold standard”
by which in vitro models should be assessed (Chow and
Broker, 1997). In human papillomavirus infections, the
impossibility of knowing when an infection began and
when a wart is about to regress makes examination of
the events in regressing lesions difficult. Clinical biop-
sies of isolated regressing warts provide some informa-
tion on the cellular immune response, but represent only
single snapshots of regression and so are difficult to
interpret. While it is possible to compare groups of warts
in advanced regression with stable or progressing warts,
studies such as these do not provide a complete chro-
nological picture of wart regression. Animal models of
mucosal papillomatosis, such as the canine and bovine
models (reviewed in Campo, 1997; Nicholls and Stanley,
1999), provide an opportunity to obtain a chronological
series of biopsies spanning the entire wart life cycle from
infection through to resolution. Canine oral papillomavi-
rus is of particular interest because experimentally in-
duced papillomas develop after only 4 to 8 weeks, and
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32 NICHOLLS ET AL.the resulting mucosal papillomas undergo rapid and
predictable regression after maturity. Since the dog
forms such an effective immune response to mucosal
papillomavirus infection, knowledge of these events may
lead to a better understanding of the key features re-
quired to clear persisting papillomavirus infections, such
as those seen in some HPV infections. Canine oral pap-
illomavirus (COPV) resembles some benign HPV infec-
tions, such as recurrent laryngeal papillomatosis, in its
ability to cause persistent and recurrent infections in
certain individuals (Nicholls et al., 1999). Furthermore,
the dog has been used as a key model in the develop-
ment of papillomavirus vaccines, including those based
on heterologous wart extracts (Bell et al., 1994; Cham-
bers et al., 1960), L1 viruslike particles (Ghim et al., 1995),
and L1-encoding DNA vaccines (our unpublished obser-
vations). Clearly, to validate the canine model, it is im-
portant to establish whether the morphological events in
regressing canine oral papillomas are similar to those
seen in regressing human mucosal papillomas.
With the recent availability of an increasing number of
immunological reagents for use in the dog (Moore and
Rossitto, 1993; Moore et al., 1990, 1992, 1994), the immu-
nology of canine oral papillomatosis is more amenable
to evaluation. The aim of this study was to understand
more clearly the immunological events in a mucosal
papillomavirus model, especially with respect to the tim-
ing of leukocyte influx in relation to wart progression and
regression. Weekly biopsies taken from experimental
COPV infections allowed a prospective longitudinal im-
munohistochemical evaluation of the events occurring
during wart progression and regression. The data indi-
cate that an influx of both CD41 and CD81 lymphocytes
begins just prior to wart regression, with maximum leu-
kocyte influx correlating with rapid wart resolution.
RESULTS
To investigate the events during regression of mucosal
papillomas, we obtained a chronological series of biop-
sies from beagles experimentally infected with canine
oral papillomavirus. Histological sections from formalin-
fixed biopsies enabled morphological examination of
papilloma regression, and cryostat sections from snap-
frozen biopsies permitted immunophenotypical analysis
of the infiltrating cells.
Wart development and regression
Scarified sites healed completely by 1 week and the
dogs had no signs of discomfort, such as reluctance to
eat, drink, or play with their toys. No macroscopic lesions
were found for the first 4 weeks after infection, so biop-
sies were taken randomly from the tattoo-marked infec-
tion sites. From week 5 postinfection, lesions were visi-
ble on the oral mucosa at the sites of infection not
already biopsied. The size of the lesions was recorded(Fig. 1) to enable correlation with leukocyte influx. The
first lesions were raised, focal, smooth, domed, single, or
multiple masses similar in colour to surrounding mu-
cosa. Lesions then increased in size, becoming more
pale and firm compared with surrounding mucosa. The
surface became irregularly textured and by 8 weeks
mature papillomas with multiple projecting papillae were
evident. In the mature 8-week warts, apoptotic keratino-
cytes were common, and in places the tips of wart
papillae had undergone focal coagulative necrosis. A
prominent lymphocytic infiltrate was present in the re-
gressing warts, and in many places the infiltrate ob-
scured the dermo-epidermal interface, accompanied by
apoptotic keratinocytes (Fig. 2). Both intracellular and
intercellular oedema were present in keratinocytes
within regressing lesions. The warts began to soften by
week 9 and had sloughed or regressed leaving only a
raised base by week 10. By week 11 there were no
obvious signs of infection, and the histological appear-
ance was similar to that of normal canine oral mucosa.
No papillomas developed other than at inoculated sites.
Immunohistochemistry of regressing lesions
Preliminary studies on formalin-fixed, paraffin-embed-
ded tissues (Nicholls and Stanley, 1996), using a CD3e
polyclonal antibody (DAKO), confirmed the presence of
numerous T cells within regressing canine oral papillo-
mas. To more accurately phenotype the inflammatory
infiltrate and to establish the timing of leukocyte influx in
relation to wart regression, a chronological series of
biopsies was obtained from beagles infected experimen-
tally with COPV. Frozen sections from weekly biopsies
were processed for immunohistochemistry. Preinfection
FIG. 1. Wart progression and regression after experimental infection.
Infections in both animals showed a similar growth pattern. The max-
imum wart diameter was measured each week. Warts were visible 5
weeks after infection and grew rapidly to reach their greatest diameter
at 8 weeks. Regression was rapid, with the lesions disappearing by 10
weeks postinfection. Infections in both animals showed a similar
growth pattern.control biopsies were used to establish the number of
cells in normal tissues.
33CANINE ORAL PAPILLOMA REGRESSIONFIG. 2. Histological sections of regressing warts. Compared with normal canine oral mucosa (a), regressing papillomas were accompanied by a
dense lymphocytic infiltrate obscuring the dermo-epidermal interface (b). Apoptotic keratinocytes were common (c). Haematoxylin and eosin. Original
magnification (a) 3100, (b) 3200, (c) 3400.
FIG. 3. Immunohistochemistry of COPV lesions. Only small numbers of CD8a1 (a) and CD41 (c) lymphocytes are found in normal canine oral
1 1mucosa. Nine weeks after infection, regressing COPV lesions contain increased numbers of both CD8a (b) and CD4 (d) lymphocytes. At low
magnification, the dense infiltrate of CD41 lymphocytes is seen to follow the dermo-epidermal interface (e). Original magnification (a–d) 3200, (e) 340.
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34 NICHOLLS ET AL.Examples of infiltrating lymphocytes in preinfection
controls and regressing warts are given in Fig. 3. The cell
counts are summarised in Fig. 4. In preinfection controls,
only a few CD41 cells were present in the epithelium,
ith a few perivascular cells in the lamina propria. A few
D8a1 and CD8b1 cells were present along the basal
layer of the epithelium, occasionally in the lamina propria
too. TCRab1 cells had a similar distribution. TCRgd1
cells were scarce, with only an occasional cell found
within the epithelium. Antibodies to CD1a, CD1c, CD11a,
and CD11c detected dendritic cells within both the epi-
thelium and the lamina propria, whereas antibodies to
CD11b detected dendritic cells in only the lamina pro-
pria. CD181 cells were present in both epithelium and
lamina propria. CD211 cells were scarce and located in
the lamina propria.
No changes in staining patterns were seen over the
FIG. 4. Cell counts during wart progression and regression. Cell cou
shown. The mean count per field is plotted against time. In H&E staine
Quantitative immunohistochemistry reveals that CD41 lymphocytes refirst 6 weeks. By week 7, foci of inflammation were seen
at the edges of the immature papilloma. At this stage, thecentral region of the papilloma had very few leukocytes
or dendritic cells compared with the inflamed edges and
the adjacent normal epithelium. The inflammatory foci
were positive after immunostaining for CD4, concen-
trated mostly in the lamina propria. Increased staining for
CD8a, CD8b, TCRab, and CD49d was seen within both
lamina propria and epithelium. Both CD1a and CD1b
showed focal increases in staining in this region, al-
though the effect was not marked. Focal increases in
number of CD11a-, CD11c-, and CD18-positive cells were
seen and distributed in epithelium and lamina propria,
whereas CD11b staining was concentrated in the lamina
propria. Although focal increases in staining of CD1 and
CD11 antibodies were seen, the total counts in the sec-
tions were not obviously different from those in earlier
weeks. No increase in TCRgd or CD21 staining was
seen.
re undertaken on weekly biopsies stained with each of the antibodies
ions, an increase in infiltrating lymphocytes can be seen from week 8.
aximum number at this time.nts weThe amount of staining for CD4, CD8, TCRab, TCRgd,
CD18, and CD49d further increased during week 8 (Fig.
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35CANINE ORAL PAPILLOMA REGRESSION3). CD41 cells were the most abundant and were at their
aximal levels at this week. TCRab, TCRgd, CD18, and
D49d were also at their peak number at week 8, but
ere less numerous than CD41 cells.
At week 9, CD4-, CD8-, TCRab-, and CD18-positive
cells remained numerous, with CD81 and TCRgd1 cells
reaching their peaks. At this point, the amount of staining
for CD1a, CD1c, CD11a, CD11b, CD11c, and CD21
peaked also. The number of TCRgd1 and CD211 cells
was comparatively small comprising below 10% of the
activity of any other antibody. The wart tissue had almost
completely regressed by week 9 and there was ulcer-
ation over a large fraction of the epithelium. The ulcer-
ation and loss of epithelium made it difficult to determine
the location of cells in densely inflamed areas.
By week 10, the intensity of staining with most of the
antibodies had subsided markedly, although CD18 and
CD49d were still prominent. By week 11, all antibodies
showed levels of staining indistinguishable from the pre-
infection control sections.
ELISA
The serum sample taken as a preinfection negative
control showed low levels of reactivity to COPV viral
particles. Samples taken 7 and 8 weeks after infection
showed similarly low levels of anti-COPV IgG antibody.
By week 11, however, a marked increase in titer to COPV
virions was seen (Fig. 5).
DISCUSSION
The spontaneous regression of COPV infections de-
scribed here is typical of lesions induced by this virus,
with only very rare exceptions (Nicholls et al., 1999).
Although COPV L1 capsid protein was detected immu-
nohistochemically in small amounts at week 7 and large
amounts at week 8 (data not shown), there is clearly a
lag before significant levels of COPV-specific IgG are
detectable in the circulation. Immunity to reinfection
seems solid in the dog, although, as with other papillo-
mavirus infections, it seems that COPV may enter a state
of latency, since we have detected COPV DNA by PCR in
oral mucosa after spontaneous lesion regression (our
unpublished data).
Previous work in the rabbit (Okabayashi et al., 1991;
Selvakumar et al., 1997), ox (Knowles et al., 1996), and
uman (Coleman et al., 1994) has demonstrated in-
reased lymphocytes in regressing warts compared with
rogressing warts, but the chronological analysis de-
cribed here in the dog has allowed a more detailed
xamination of these events. In the dog, the influx of
ymphocytes began just prior to regression, peaked dur-
ng lesion resolution, and returned to preinfection levels
hen the lesions had resolved. Although similar in-
reased leukocyte numbers have been reported in other
pecies, some important differences are present, al-hough care should be taken when comparing studies
ith different methodologies, due to possible differences
n timing of the biopsies and sensitivity of the immuno-
istochemistry. In regressing cottontail rabbit papilloma-
irus (CRPV)-induced papillomas, dense T-lymphocyte
nfiltrates were seen within the basal region of the epi-
ermis and in adjacent dermis (Okabayashi et al., 1991).
This distribution was similar to that seen in COPV le-
sions, in which the infiltrate often obscured the interface
zone. This pattern of interface dermatitis is typical of
immune-mediated skin disease in the dog and human. In
contrast to COPV lesions, the infiltrate in CRPV warts
comprised predominantly CD81 lymphocytes within the
asal and suprabasal layers of epithelium (Selvakumar
t al., 1997) with no CD41 cells demonstrable. The scar-
city of CD41 cells in the CRPV lesions is noteworthy,
considering their abundance in the COPV lesions. This
may represent a true biological difference between rab-
bit and other animals including dog and human. How-
ever, while the anti-rabbit CD4 antibody was reported to
work well on spleen sections, it was described as being
FIG. 5. COPV ELISA of sequential serum samples during experimen-
tal infection. Preinfection serum (c) had low levels of antibody to native
COPV virions. Although viral L1 capsid protein can be detected immu-
nohistochemically in lesions at weeks 7 (n) and 8 () (data not shown),
no increase in capsid antibody is detectable at these points. By week
11 (N), after wart regression, the serum contains high levels of antibody
to native COPV virions.nonspecific on the papilloma sections, suggesting that
further work in the rabbit may be required to address this
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36 NICHOLLS ET AL.issue. It seems that keratinocyte apoptosis may play an
important role in COPV lesion regression, since in this
study it correlated both spatially and temporally with
lymphocytic infiltration and wart regression. No obvious
necrosis was seen associated with the cellular infiltrate
in CRPV lesions (Selvakumar et al., 1997).
CRPV affects haired skin and the results obtained in
the dog need comparing with another mucosal papillo-
mavirus infection. BPV-4 provides such an opportunity,
and there were some important differences from the data
obtained in the rabbit and dog. The infiltrate in regress-
ing BPV-4 papillomas had numerous CD41 cells in the
ermis (Knowles et al., 1996), as in the COPV lesions.
The predominance of CD41 cells in BPV and COPV
lesions suggests they are playing a key role, perhaps
with TH1 CD4
1 cells activating macrophages, or by cyto-
kine-mediated inhibition or killing of infected keratino-
cytes. The timing of the CD41 cell appearance seen in
the dog is consistent with their playing a primary role,
since they appear just before the onset of regression.
CD11, CD11a–c1, and CD211 cells, however, peaked
nly once regression was underway, perhaps respond-
ng to secondary infection from the loss of epithelial
ntegrity, or responding to tissue necrosis in the regress-
ng wart. This important difference in the timing of leu-
ocyte influx is apparent only with frequent sequential
iopsies and is an issue not addressed in previous
tudies.
The CD41 cells in regressing BPV-4 papillomas were
present mostly as subepithelial clusters within the der-
mis, sometimes surrounded by CD81 and TCRgd1 cells,
ut migrating more into the epithelium once the basal
amina had been breached (Knowles et al., 1996). Al-
hough subepithelial foci of CD41 cells were seen in the
anine lesions, the pattern described for BPV-4 lesions
as not prominent. A major departure from the findings
oted in BPV-4 lesions was the paucity of TCRgd1 cells
n COPV lesions. Ruminants have abundant TCRgd1
cells, and these were more numerous than CD81 cells in
he BPV-4 lesions (Knowles et al., 1996). Normal canine
oral mucosa has increased numbers of gamma/delta T
cells compared with normal canine haired skin (Cannon
et al., 1998) although, from the findings reported here,
their role in clearance of papillomavirus infections
seems minor, at least with respect to the number of cells
involved.
Numerous lymphocytes are seen in regressing human
anogenital warts (Coleman et al., 1994). The scarcity of
B-cells (CD211) seen in COPV lesions was noted also
for the HPV lesions. An increase in number of both CD41
and CD81 cells was common to regressing lesions of
both COPV and HPV, as was an increase in the number
of intraepithelial CD41 cells during regression. Although
lymphocytes were the most common infiltrating cell in
the regressing HPV lesions, macrophages were seen
also. No changes in Langerhans cell number were seenin the regressing HPV lesions. A different study reported
a reduction in CD1a1 Langerhans cell number in low-
and high-grade cervical disease, compared with normal
cervical epithelium (Mota et al., 1998). The COPV lesions
had a late increase in Langerhans cells and dermal
dendritic cells, noted after regression had started. Al-
though not reflected in the mean for the section, week 7
canine papillomas appeared to have fewer Langerhans
cells within the wart epithelium compared with adjacent
normal epithelium, suggesting activation and migration
to the draining lymph nodes.
It is important to exercise caution in extrapolating data
from animal to human models. Although there are impor-
tant differences in the immune systems of dog and hu-
man, such as the expression of CD4 on canine neutro-
phils (Moore et al., 1992), there is much overlap in cell
surface antigen markers and cell function both in lym-
phocytes and in antigen presenting cells (Marchal et al.,
1995). Functional overlap is suggested also by the clini-
cal and immunological similarities between canine and
human immune-mediated diseases, including X-linked
severe combined immunodeficiency (Felsburg et al.,
1998; Hartnett et al., 2000), bullous pemphigoid (Xu et al.,
2000), systemic lupus erythematosus (Chabanne et al.,
1995), and gluten-sensitive enteropathy (Hall and Batt,
1990). Furthermore, the dog has a long history as a
model for the development of organ transplantation in
the human (Ladiges et al., 1990; Starzl, 2000; Wagner et
al., 1999). In humans, gamma/delta T-cells form only a
minority of the peripheral T-lymphocyte pool, whereas
they are present in strikingly increased numbers in the
peripheral blood of ruminants, especially young cattle
(Hass et al., 1993; Hein and Mackay, 1991; Wyatt et al.,
1994). Additionally, the normal white cell count of cattle is
different from that of humans and generally comprises
fewer neutrophils, more lymphocytes, and more eosino-
phils (Hope, 1998; Jain, 1993). Canine normal white cell
counts fall within the normal ranges quoted for humans
(Hope, 1998; Jain, 1993) and in the dog, the low numbers
of gamma/delta T-cells in normal haired skin (Cannon et
al., 1998) are similar to the findings reported in humans
(Alaibac et al., 1992). In the rabbit also, the gamma/delta
T-cell proportion in peripheral blood is relatively high
compared with the human (Sawasdikosol et al., 1993).
Although the rabbit continues to play an important role in
studies of papillomavirus immunity and vaccine develop-
ment, it should be remembered that B-cell diversification
in the rabbit, unlike that in other mammals, occurs in the
lymphoid tissue of the appendix in a manner analogous
to that occurring in the Bursa of Fabricius in birds (Pas-
toret et al., 1998).
In summary, these data show that a predominantly
T-cell infiltrate appeared mainly at the dermo-epidermal
junction just prior to morphological regression, becom-
ing maximal during the period of rapid wart regression.
CD41 cells were more abundant than CD81 cells. Addi-
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37CANINE ORAL PAPILLOMA REGRESSIONtionally, frequent biopsy appears to be required to avoid
confusion of primary immune infiltrates with likely sec-
ondary inflammatory infiltrates. These observations sup-
port the findings reported for regressing human anogeni-
tal warts (Coleman et al., 1994) and confirm that the
anine system is likely to be a good model for human
apillomavirus immunity studies and vaccine develop-
ent. Since the response was clearly very effective in
learing mucosal papillomas, effective therapeutic strat-
gies should aim at stimulating this type of immunity.
MATERIALS AND METHODS
xperimental infection
Two female beagles aged 10–12 weeks, obtained from
colony with no history of COPV infection, were housed
n purpose-built, climate-controlled accommodation. To
inimise the chances of crossinfection to and from other
ogs in the unit, all dogs in this study were housed in an
irspace separate from other dogs in the building, with a
irucidal (Virkon, Antec International, Suffolk, UK) foot-
ath at the common entrance and exit. All staff changed
heir protective clothing (gown, gloves, boots) on enter-
ng the controlled area.
After a 10-day acclimatisation period, followed by over-
ight withdrawal of food, animals were examined and
eighed before premedication with acepromazine mal-
ate (0.03 mg/kg) as a sedative and buprenorphine hy-
rochloride (10 mg/kg) as an analgesic. Anaesthesia was
induced by intravenous sodium thiopentone (2.5%) at
approximately 10 mg/kg to effect and maintained with
halothane and oxygen. The mucosa of the upper lip was
lightly scarified over an area approximately 5 3 5 mm,
using the tip of a scalpel blade, until a light ooze of blood
occurred. An aliquot of 10 ml of homogenized canine oral
apilloma extract (Bell et al., 1994), kindly donated by A.
ennet Jenson, was applied to each site by pipette and
llowed to absorb for a few minutes. The site of chal-
enge was marked by Indian ink tattoo points in a triangle
entred on the site. Twelve sites were infected in each
og. Control blood samples and biopsies were taken
rior to challenge and weekly thereafter. The maximum
art diameter was measured each week. At the end of
he study, the animals were rehomed.
lood sampling and mucosal biopsy preparation
Under general anaesthesia and after preinfection con-
rol biopsies, further weekly biopsies of the oral mucosa
ere taken using a 6-mm punch biopsy or scalpel, fol-
owed by suturing as appropriate. Where gross lesions
ad not yet developed, tissue was taken from the tattoo-
arked sites. The biopsies were split and either fixed in
0% neutral-buffered formalin or embedded in optimal
utting temperature compound (OCT, BDH) and frozen in
sopentane (BDH) cooled to its freezing point in liquid pitrogen. Formalin-fixed samples were processed after
–8 h to paraffin wax for routine (5–7 mm) sectioning.
rozen tissue was stored at 270°C prior to cryostat
ectioning. Blood samples were taken from the jugular
ein during anaesthesia, and the serum frozen at 220°C.
mmunohistochemistry of serial biopsies
Cryostat sections (7 mm) were fixed in acetone for 2
min and then immersed in 0.3% hydrogen peroxide in
0.1% w/v sodium azide for 10 min. After rinsing in PBS for
3 min, the sections were incubated in 10% normal goat
serum in PBS for 30 min. All further incubations were for
30 min at room temperature in a humidified box. The
blocking serum was tipped and blotted off before addi-
tion of the 1/10 diluted primary antibody (Table 1). Sec-
tions were washed in PBS (3 3 5 min) before incubation
with the 1/400 diluted biotinylated goat anti-mouse IgG1
or IgG2a (Amersham). After further washes in PBS (3 3
5 min), the sections were incubated with peroxidase-
conjugated avidin–biotin complex (Vectastain Elite, Vec-
tor Labs.) and developed with DAB (0.06% 3,39 diamino-
benzidine tetrahydrochloride, 0.01% hydrogen peroxide
in 0.1 M Tris, pH 7.5) according to the manufacturer’s
instructions. Sections were counterstained with Carazzi’s
haematoxylin and mounted in di-butyl-polystrene-xylene
(DPX). Frozen sections from lymph nodes were used as
positive controls. Omission of the primary or secondary
antibody was used as a negative control.
Cell counting from immunostained sections
Sections were examined by light microscopy with a
325 objective. Positive-staining cells were counted
throughout the epidermis and the uppermost field of
underlying dermis using an eyepiece graticule. All fields
extending horizontally from one edge of the biopsy to the
other edge were counted. Each field measured 400 mm2.
Where cells within a graticule subdivision (40 mm2) were
so abundant and closely packed that they were innumer-
able, the subdivision was allocated a count of 10 cells.
The counts were repeated on two or more different
sections and the mean count per field was calculated.
ELISA
ELISA was undertaken as previously described (Ni-
cholls et al., 1999) using 100 ng per well of purified COPV
particles in carbonate buffer and 50 ml aliquots of 10-fold
serum dilutions, from samples taken at 0, 7, 8, and 11
weeks postinfection, added to duplicate wells of the
coated plates. After incubation and washing, peroxidase-
conjugated, rabbit anti-dog IgG (1/500, ICN Immunobio-
logicals) was added to all wells. Following incubation
and a final wash, the plates were developed using an
s-phenylene diamine/peroxide substrate in urea buffer
(Sigmafast). The reciprocal of the log10 dilutions was
lotted against the absorbance at 490 nm.
CC
C
C
C
C
C
C
C
ns cel
38 NICHOLLS ET AL.ACKNOWLEDGMENTS
This work was supported by the Biotechnology and Biological Sci-
ences Research Council (Grant S08647). P.K.N. was supported by a
BBSRC Veterinary Research Fellowship. The COPV wart homogenate
was a generous gift from A. B. Jenson, Georgetown University, Wash-
ington, D.C. The monoclonal antibodies specified in Table 1 were from
the laboratory of Peter F. Moore. Madeline Fordham and Andrea Kemp,
Histology, Dept. of Clinical Veterinary Medicine, undertook the paraffin
section preparation.
REFERENCES
Alaibac, M., Morris, J., Yu, R., and Chu, A. C. (1992). T lymphocytes
bearing the gamma/delta T-cell receptor: A study in normal human
skin and pathologic skin conditions. Br. J. Dermatol. 127, 458–462.
Anonymous. (1996). “Human Papillomaviruses.” IARC Monographs on
the Evaluation of Carcinogen Risks to Humans, Vol. 64. World Health
Organization International Agency for Research on Cancer, Lyon,
France.
Bell, J. A., Sundberg, J. P., Ghim, S. J., Newsome, J., Jenson, A. B., and
Schlegel, R. (1994). A formalin-inactivated vaccine protects against
mucosal papillomavirus infection—A canine model. Pathobiology
62, 194–198.
Beutner, K. R., and Ferenczy, A. (1997). Therapeutic approaches to
genital warts. Am. J. Med. 102, 28–37.
ampo, M. S. (1997). Vaccination against papillomavirus in cattle. Clin.
Dermatol. 15, 275–283.
annon, A. G., Olivry, T., Ihrke, P. J., Naydan, D. K., and Moore, P. F.
(1998). Gamma delta cells in normal and diseased canine skin. In
“Advances in Veterinary Dermatology” (K. W. Kwochka, T. Willemse,
and C. von Tscharner, Eds.), Vol. 3, pp. 137–143. Butterworth and
Heinemann, Oxford, U.K.
habanne, L., Fournel, C., Caux, C., Bernaud, J., Bonnefond, C., Monier,
J. C., and Rigal, D. (1995). Abnormalities of lymphocyte subsets in
canine systemic lupus erythematosus. Autoimmunity 22, 1–8.
hambers, V. C., Evans, C. A., and Weiser, R. S. (1960). Canine oral
papillomatosis. II. Immunologic aspects of the disease. Cancer Res.
20, 1083–1093.
T
Origin and Specific
Clone Isotype
A15.8G7 IgG1 TCRab, T-cell receptor, major subset (Moore
CA20.8H1 IgG2a TCRgd, T-cell receptor, minor subset (Moore
CA9.AG5 IgG1 CD1a, Langerhans cells, dermal dendritic cel
CA13.9H11 IgG1 CD1c, Langerhans cells, dermal dendritic cel
A13.1E4 IgG1 CD4, Helper TH2 and inflammatory TH1 T cell
CA9.JD3 IgG2a CD8a, MHC-I coreceptor, cytotoxic T-cells (C
CA15.4G2 IgG1 CD8b, MHC-I coreceptor, cytotoxic T-cells (C
CA11.4D3 IgG1
CD11a, LFA-1, granulocytes, monocytes, T-ce
(Danilenko et al., 1992; Marchal et al., 1995
CA16.3E10 IgG1
CD11b, Mac-1, granulocytes, monocytes, som
Moore et al., 1996)
CA11.6A1 IgG1
CD11c, monocytes, Kupffer cells, granulocyte
al., 1995; Moore et al., 1996)
CA1.4E9 IgG1
CD18, b2-integrins, thymocytes, most periphe
Marchal et al., 1995; Moore et al., 1990)
CA2.1D6 IgG1 CD21, B-cells (Cobbold and Metcalfe, 1994, M
CA4.5B3 IgG1 CD49d, a4 integrin, VLA-4, activated Langerhahow, L. T., and Broker, T. R. (1997). In vitro experimental systems for
HPV: Epithelial raft cultures for investigations of viral reproductionand pathogenesis and for genetic analysis of viral proteins and
regulatory sequences. Clin. Dermatol. 15, 217–227.
obbold, S., and Metcalfe, S. (1994). Monoclonal antibodies that define
canine homologues of human CD antigens. Summary of the First
International Canine Leukocyte Antigen Workshop (CLAW). Tissue
Antigens 43, 137–154.
oleman, N., Birley, H. D., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne,
M., Taylor Robinson, D., and Stanley, M. A. (1994). Immunological
events in regressing genital warts. Am. J. Clin. Pathol. 102, 768–774.
Danilenko, D. M., Moore, P. F., and Rossitto, P. V. (1992). Canine
leukocyte cell adhesion molecules (LeuCAMs): Characterization of
the CD11/CD18 family. Tissue Antigens 40, 13–21.
Felsburg, P. J., Somberg, R. L., Hartnett, B. J., Henthorn, P. S., and
Carding, S. R. (1998). Canine X-linked severe combined immunode-
ficiency. A model for investigating the requirement for the common
gamma chain (gamma c) in human lymphocyte development and
function. Immunol. Res. 17, 63–73.
Frattini, M. G., Lim, H. B., and Laimins, L. A. (1996). In vitro synthesis of
oncogenic human papillomaviruses requires episomal genomes for
differentiation-dependant late gene expression. Proc. Natl. Acad. Sci.
USA 93, 3062–3067.
Ghim, S.-J., Newsome, J., Jenson, A. B., Schlegel, R., Suzich, J., Tamura,
J., White, W., Hill, F., Warrener, P., Bell, J. A., and Sundberg, J. (1995).
Formalin-inactivated oral papilloma extracts and recombinant L1
vaccines protect completely against mucosal papillomavirus infec-
tion: A canine model. Vaccines 95 25, 375–379.
Hall, E. J., and Batt, R. M. (1990). Development of wheat-sensitive
enteropathy in Irish setters: Morphologic changes. Am. J. Vet. Res. 51,
978–982.
Hartnett, B. J., Somberg, R. L., Krakowka, S., Ochs, H. D., HogenEsch, H.,
Moore, P. F., Weinberg, K. I., and Felsburg, P. J. (2000). B-cell function
in canine X-linked severe combined immunodeficiency. Vet. Immu-
nol. Immunopathol. 75, 121–134.
Hass, W., Pareira, P., and Tonegawa, S. (1993). Gamma/delta cells. Ann.
Rev. Immunol. 11, 637–685.
Hein, W. R., and Mackay, C. R. (1991). Prominence of gamma/delta T
cells in the ruminant immune system. Immunol. Today 12, 30–34.
Hope, R. A., Ed. (1998). “Oxford Handbook of Clinical Medicine.” 4th ed.
rimary Antibodies
ificity and references
ssitto, 1993)
994)
ilenko et al., 1992; Marchal et al., 1995; Moore et al., 1996)
ilenko et al., 1992; Marchal et al., 1995; Moore et al., 1996)
ophils (Moore et al., 1992)
and Metcalfe, 1994; Moore et al., 1992)
and Metcalfe, 1994, Moore et al., 1992)
cells, Langerhans cells, follicular dendritic cells, Kupffer cells
e et al., 1996)
hocytes (NK cells?), not Langerhans cells (Danilenko et al., 1992;
erhans and dermal dendritic cells (Danilenko et al., 1992; Marchal et
ocytes, dermal and epithelial dendritic cells (Danilenko et al., 1992;
t al., 1992)
ls (Cobbold and Metcalfe, 1994; Moore et al., 1992)ABLE 1
ity of P
Spec
and Ro
et al., 1
ls (Dan
ls (Dan
s, neutr
obbold
obbold
lls, NK-
; Moor
e lymp
s, Lang
ral leuc
oore eOxford Univ. Press, Oxford, U.K.
Jain, N. C. (1993). Comparative hematology of common domestic ani-
LS
S
S
S
W
W
W
W
X
39CANINE ORAL PAPILLOMA REGRESSIONmals. In “Essentials of Veterinary Hematology,” pp. 20–21. Lea and
Febiger, Philadelphia.
Knowles, G., O’Neil, B. W., and Campo, M. S. (1996). Phenotypical
characterisation of lymphocytes infiltrating regressing papillomas.
J. Virol. 70, 8451–8458.
adiges, W. C., Storb, R., and Thomas, E. D. (1990). Canine models of
bone marrow transplantation. Lab. Anim. Sci. 40, 11–15.
Marchal, T., Saint-Andre, I., Magnol, J. P., Dezutter-Dambuyant, C., and
Schmitt, D. (1995). Dendritic cells in dogs and cats: Models of study
in human pathology. Pathol. Biol. (Paris) 43, 910–920.
Meyers, C., Frattini, M. G., Hudson, J. B., and Laimins, L. A. (1992).
Biosynthesis of human papillomavirus from a continuous cell line
upon epithelial differentiation. Science 257, 971–973.
Moore, P. F., and Rossitto, P. V. (1993). Development of monoclonal
antibodies to the canine T cell receptor complex (TCR/CD3) and their
utilisation in the diagnosis of T cell neoplasia. Vet. Pathol. 30, 457.
Moore, P. F., Rossitto, P. V., and Danilenko, D. M. (1990). Canine
leukocyte integrins: Characterization of a CD18 homologue. Tissue
Antigens 36, 211–220.
Moore, P. F., Rossitto, P. V., Danilenko, D. M., Wielenga, J. J., Raff, R. F.,
and Severns, E. (1992). Monoclonal antibodies specific for canine
CD4 and CD8 define functional T-lymphocyte subsets and high-
density expression of CD4 by canine neutrophils. Tissue Antigens
40, 75–85.
Moore, P. F., Rossitto, P. V., and Olivry, T. (1994). Development of
monoclonal antibodies to canine T cell receptor-1 (TCRgd) and their
utilization in the diagnosis of epidermotropic cutaneous T-cell lym-
phoma. Vet. Pathol. 31, 597.
Mota, F. F., Rayment, N. B., Kanan, J. H., Singer, A., and Chain, B. M.
(1998). Differential regulation of HLA-DQ expression by keratinocytes
and Langerhans cells in normal and premalignant cervical epithe-
lium. Tissue Antigens 52, 286–293.
Nicholls, P. K., Klaunberg, B. A., Moore, R. A., Santos, E. B., Parry, N. R.,
Gough, G. W., and Stanley, M. A. (1999). Naturally occurring, non-
regressing canine oral papillomavirus infection: host immunity, virus
characterization, and experimental infection. Virology 265, 365–374.
Nicholls, P. K., and Stanley, M. A. (1996). Canine oral papillomavirus—A
model for human papillomavirus regression. BBSRC Comparative
Immunology Workshop Proceedings, p. 19. Biotechnology and Bio-
logical Sciences Research Council, Swindon, U.K.
Nicholls, P. K., and Stanley, M. A. (1999). Canine papillomavirus—A
centenary review. J. Comp. Pathol. 120, 219–233.
Okabayashi, M., Angell, M. G., Christensen, N. D., and Kreider, J. W.
(1991). Morphometric analysis and identification of infiltrating leuco-
cytes in regressing and progressing Shope rabbit papillomas. Int. J.
Cancer 49, 919–923.Palefsky, J. M., Holly, E. A., Ralston, M. L., and Jay, N. (1998). Prevalence
and risk factors for human papillomavirus infection of the anal canal
in human immunodeficiency virus (HIV)-positive and HIV-negative
homosexual men. J. Infect. Dis. 177, 361–367.
Pastoret, P. P., Griebel, P., Bazin, H., and Govaerts, A. (1998). Immunol-
ogy of Lagomorphs, Chapter VI. In “Handbook of Vertebrate Immu-
nology,” pp. 223–260. Academic Press, London.
Sawasdikosol, S., Hague, B. F., Zhao, T. M., Bowers, F. S., Simpson,
R. M., Robinson, T., and Kindt, J. (1993). Selection of rabbit CD4- CD8-
TCRgd cells by in vitro transformation with HTLV-1. J. Exp. Med. 178,
1337–1345.
Selvakumar, R., Schmitt, A., Iftner, T., Ahmed, R., and Wettstein, F. O.
(1997). Regression of papillomas induced by cottontail rabbit papil-
lomavirus is associated with infiltration of CD81 cells and persis-
tence of viral DNA after regression. J. Virol. 71, 5540–5548.
hah, K. V., and Howley, P. M. (1996). Papillomaviruses. In “Virology”
(B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), Vol. 2, pp.
2077–2109. Lippincott–Raven, Philadelphia.
tanley, M. A. (1994a). Replication of human papillomaviruses in cell
culture. Antiviral Res. 24, 1–15.
tanley, M. A. (1994b). Virus-keratinocyte interactions in the infectious
cycle. In “Human Papillomaviruses and Cervical Cancer—Biology
and Immunology” (P. L. Stern, and M. A. Stanley, Eds.), pp. 116–131.
Oxford University Press, Oxford, U.K.
tarzl, T. E. (2000). History of clinical transplantation. World J. Surg. 24,
759–782.
agner, J. L., Burnett, R. C., and Storb, R. (1999). Organization of the
canine major histocompatibility complex: Current perspectives.
J. Hered. 90, 35–38.
alboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer,
J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J., and Munoz, N.
(1999). Human papillomavirus is a necessary cause of invasive
cervical cancer worldwide. J. Pathol. 189, 12–19.
hite, W. J., Wilson, S. D., Bonnez, W., Rose, R. C., Koenig, S., and
Suzich, J. A. (1998). In vitro infection and type-restricted antibody-
mediated neutralization of authentic human papillomavirus type 16.
J. Virol. 72, 959–964.
yatt, C. R., Madruga, C., Cluff, S., Parish, S., Hamilton, M. J., Goff, W.,
and Davis, W. C. (1994). Differential distribution of gd T cell receptor
lymphocyte subpopulations in blood and spleen of young and adult
cattle. Vet. Immunol. Immunopathol. 40, 187–199.
u, L., O’Toole, E. A., Olivry, T., Hernandez, C., Peng, J., Chen, M., and
Chan, L. S. (2000). Molecular cloning of canine bullous pemphigoid
antigen 2 cDNA and immunomapping of NC16A domain by canine
bullous pemphigoid autoantibodies. Biochim. Biophys. Acta 1500,
97–107.
